Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.9 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0089 | 0.9 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |